BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 27634346)

  • 61. MiR-217 promotes cutaneous squamous cell carcinoma progression by targeting PTRF.
    Bai M; Zhang M; Long F; Yu N; Zeng A; Wang X
    Am J Transl Res; 2017; 9(2):647-655. PubMed ID: 28337292
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Activating transcription factor 1 promoted migration and invasion in lung cancer cells through regulating EGFR and MMP-2.
    Cui J; Yin Z; Liu G; Chen X; Gao X; Lu H; Li W; Lin D
    Mol Carcinog; 2019 Oct; 58(10):1919-1924. PubMed ID: 31420907
    [TBL] [Abstract][Full Text] [Related]  

  • 63. LSR Promotes Cell Proliferation and Invasion in Lung Cancer.
    Zhang M; Ma C
    Comput Math Methods Med; 2021; 2021():6651907. PubMed ID: 33763152
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Increased expression of insulin-like growth factor-II messenger RNA-binding protein 1 is associated with tumor progression in patients with lung cancer.
    Kato T; Hayama S; Yamabuki T; Ishikawa N; Miyamoto M; Ito T; Tsuchiya E; Kondo S; Nakamura Y; Daigo Y
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):434-42. PubMed ID: 17255263
    [TBL] [Abstract][Full Text] [Related]  

  • 65. POU2F2 promotes the proliferation and motility of lung cancer cells by activating AGO1.
    Luo R; Zhuo Y; Du Q; Xiao R
    BMC Pulm Med; 2021 Apr; 21(1):117. PubMed ID: 33832481
    [TBL] [Abstract][Full Text] [Related]  

  • 66. PTRF/cavin-1 remodels phospholipid metabolism to promote tumor proliferation and suppress immune responses in glioblastoma by stabilizing cPLA2.
    Yi K; Zhan Q; Wang Q; Tan Y; Fang C; Wang Y; Zhou J; Yang C; Li Y; Kang C
    Neuro Oncol; 2021 Mar; 23(3):387-399. PubMed ID: 33140095
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The clinical significance of MIA gene in tumorigenesis of lung cancer.
    Gu QH; Li D; Xie ZH; Shen QB
    Neoplasma; 2020 May; 67(3):660-667. PubMed ID: 31986890
    [TBL] [Abstract][Full Text] [Related]  

  • 68. BAI1‑associated protein 2‑like 2 is a potential biomarker in lung cancer.
    Xu L; Du H; Zhang Q; Wang C; Yan L; Tian G; Fu X
    Oncol Rep; 2019 Feb; 41(2):1304-1312. PubMed ID: 30483805
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Role of Cavin3 in the Progression of Lung Cancer and Its Mechanism.
    Sun G; Ni K
    Biomed Res Int; 2020; 2020():6364801. PubMed ID: 32352004
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A systematic analysis of orphan cyclins reveals CNTD2 as a new oncogenic driver in lung cancer.
    Gasa L; Sanchez-Botet A; Quandt E; Hernández-Ortega S; Jiménez J; Carrasco-García MA; Simonetti S; Kron SJ; Ribeiro MP; Nadal E; Villanueva A; Clotet J
    Sci Rep; 2017 Aug; 7(1):10228. PubMed ID: 28860486
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular and clinical characterization of PTRF in glioma via 1,022 samples.
    Sun S; Yang C; Wang K; Huang R; Zhang KN; Liu Y; Cao Z; Zhao Z; Jiang T
    BMC Cancer; 2023 Jun; 23(1):551. PubMed ID: 37322408
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sperm‑associated antigen 4 (SPAG4) as a new cancer marker interacts with Nesprin3 to regulate cell migration in lung carcinoma.
    Ji Y; Jiang J; Huang L; Feng W; Zhang Z; Jin L; Xing X
    Oncol Rep; 2018 Aug; 40(2):783-792. PubMed ID: 29901114
    [TBL] [Abstract][Full Text] [Related]  

  • 73. NOB1: A Potential Biomarker or Target in Cancer.
    Ke W; Lu Z; Zhao X
    Curr Drug Targets; 2019; 20(10):1081-1089. PubMed ID: 30854959
    [TBL] [Abstract][Full Text] [Related]  

  • 74. E3 ligase SOCS3 regulates NOD2 expression by ubiquitin proteasome system in lung cancer progression.
    Jeong IH; Yun JK; Jin JO; Hong JH; Lee JY; Lee GD; Lee PC
    Cell Oncol (Dordr); 2023 Nov; ():. PubMed ID: 37910276
    [TBL] [Abstract][Full Text] [Related]  

  • 75. miR-208a-3p suppresses cell apoptosis by targeting PDCD4 in gastric cancer.
    Yin K; Liu M; Zhang M; Wang F; Fen M; Liu Z; Yuan Y; Gao S; Yang L; Zhang W; Zhang J; Guo B; Xu J; Liang H; Chen X; Guan W
    Oncotarget; 2016 Oct; 7(41):67321-67332. PubMed ID: 27634902
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Role and mechanism of miR-187 in human cancer.
    Peng W; Sha H; Sun X; Zou R; Zhu Y; Zhou G; Feng J
    Am J Transl Res; 2020; 12(9):4873-4884. PubMed ID: 33042395
    [TBL] [Abstract][Full Text] [Related]  

  • 77. miR-1301-3p promotes the proliferation and migration of lung cancer cells via direct repression of polymerase I and transcript release factor.
    Wu Y; Shen Q; Chen X; Wu Y; Niu Y; Lv F
    Oncol Lett; 2020 Dec; 20(6):286. PubMed ID: 33014164
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Homotrimer cavin1 interacts with caveolin1 to facilitate tumor growth and activate microglia through extracellular vesicles in glioma.
    Wang L; Yang C; Wang Q; Liu Q; Wang Y; Zhou J; Li Y; Tan Y; Kang C
    Theranostics; 2020; 10(15):6674-6694. PubMed ID: 32550897
    [No Abstract]   [Full Text] [Related]  

  • 79. Systematic analyses of genetic variants in chromatin interaction regions identified four novel lung cancer susceptibility loci.
    Ji P; Ding D; Qin N; Wang C; Zhu M; Li Y; Dai J; Jin G; Hu Z; Shen H; Chen L; Ma H
    J Cancer; 2020; 11(5):1075-1081. PubMed ID: 31956354
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical significance of high expression of miR-452-5p in lung squamous cell carcinoma.
    Gan XN; Gan TQ; He RQ; Luo J; Tang RX; Wang HL; Zhou H; Qing H; Ma J; Hu XH; Chen G
    Oncol Lett; 2018 May; 15(5):6418-6430. PubMed ID: 29616113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.